Apr 20, 2023
In this episode, host Shikha Jain, MD, speaks
with CureMatch CEO Navid Alipour about the rise of
AI in the health care space, how technology can elevate the ways in
which we diagnose and deliver health care and more.
• Welcome to another exciting episode of Oncology
Overdrive :14
• About Alipour :28
• The interview 1:34
• How did you get into the AI space?
2:06
• Can you talk about the evolution of AI from before
to where we are now? 4:37
• What are the ways in which you see technologies like
CureMatch and CureMetrix having an impact, and what do they do?
9:51
• Alipour and Jain on utilizing AI in ways that will
benefit the patient and help providers deliver better care
17:47
• Do you think that there’s a role for AI and these
types of technologies in the space of addressing inequities,
providing better care and potentially fixing pervasive issues
within the modern-day health care system?
26:52
• Jain and Alipour on how quickly technology has
evolved, and how it can be utilized in health care detection
32:55
• If someone could only listen to the few minutes of
this episode, what would you want them to take away?
38:23
• Alipour and Jain on the importance of patient
advocacy 38:58
• How to contact Alipour
41:16
• Thanks for listening
42:54
Navid Alipour is the co-founder and CEO of
CureMatch, a company focused on artificial intelligence (AI)
technology. He is also a founder of an AI-focused VC fund,
Analytics Ventures.
We’d love to hear from you! Send your comments/questions to Dr.
Jain at oncologyoverdrive@healio.com. Follow us on Twitter
@HemOncToday and @ShikhaJainMD. Alipour can be reached at
curematch.com and curemetrix.com, or on Twitter @CureMatch and
@CureMetrix.
Disclosures: Jain reports no relevant
financial disclosures. Alipour reports he is the founder of
CureMatch.